EC Ophthalmology

Introduction: Acute posterior multifocal placoid pigment epitheliopathy APMPPE is a self-limiting disease non granulomatous inflammation of unknown ideology, it usually affects healthy young men and women, full recovery of the vision occurs after few months. We present a case that we followed her up for 3 years with recurrent attacks of choroiditis with atypical presentation of APMPPE that resulted in permanent loss of vision, she needed more than one immunosuppressant to control the disease.

Purpose: To highlight the presentation and management of atypical cases of uveitis. Early treatment can prevent visual loss.

Setting/Venue: Ophthalmology department at Ashford & St. Peter’s Hospitals NHS Foundation Trust.

Keywords: White Dot Syndromes; Inflammatory Chorioretinopathy; Covid-19 Dilemma; Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)

1. BE Jones., et al. “Relentless placoid chorioretinitis: A new entity or an unusual variant of serpiginous chorioretinitis?” Archives of Ophthalmology7 (2000): 931-938.
2. S Daniele., et al. “Progression of choroidal atrophy in acute posterior multifocal placoid pigment epitheliopathy”. Ophthalmologica1 (1998): 66-72.
3. M Olivia Jorge Simao Claudia Farinha. “Management of Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): Insight from multimodal imaging with OCTA”. Ophthalmological Medicine (2020).